Healthcare provider and drug dispenser knowledge and adherence to guidelines for the case management of malaria in pregnancy in the context of multiple first-line artemisinin-based combination therapy in western Kenya

Table 3 Provider knowledge of national malaria treatment guidelines in pregnancy by facility type

	Overall			Health facilities			Drug outlets			p-value*
	n = 174	%	95% CI	n = 134	%	95% CI	n = 40	%	95% CI	p-value*
Awareness of MTGs	99	57	(49–64)	83	62	(52–70)	16	40	(26–55)	0.023
Training in MiP	74	43	(35–50)	66	49	(41–58)	8	20	(10–35)	0.002
Pregnancy assessment	163	94	(89–97)	132	98	(95–100)	31	78	(62–88)	< 0.001
Treatment and dosage
1st trimester
Correct drug named	144	83	(76–88)	121	90	(84–94)	23	58	(42–71)	< 0.001
Correct drug and dosage	55	32	(25–39)	48	36	(28–44)	7	18	(9–32)	0.05
2nd /3rd Trimester
Correct drug named	141	81	(75–86)	113	84	(77–90)	28	70	(55–82)	0.07
Correct drug and dosage	60	34	(28–42)	48	36	(28–44)	12	30	(18–45)	0.62
Severe MiP
Correct drug named	150	86	(80–91)	126	94	(87–97)	24	60	(45–74)	< 0.001
Correct drug and dosage	90	52	(44–59)	73	54	(46–63)	17	43	(29–58)	0.25
Adequate knowledge**
Correct drug and dosage	19	11	(7–16)	14	10	(6–17)	5	12	(5–26)	0.77
Parasitological diagnosis and correct drug with dosage	18	11	(7–16)	13	10	(6–16)	5	12	(5–26)	0.57

*Fisher’s exact test used for strata with < 5 observations. Acronyms: MTGs- malaria treatment guidelines; MiP - malaria in pregnancy; Tri - trimester of pregnancy
**correct drug and dosage for uncomplicated malaria in all trimesters and complicated malaria

ISSN: 1475-2875